Myeloma Other
Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis
MYD88在淋巴浆细胞淋巴瘤的诊断和发病机制中的作用
Mutations in chronic lymphocytic leukemia, and how they impact therapy choice: Focus on NOTCH1, SF3B1, and TP53
慢性淋巴细胞白血病相关突变及其对治疗选择的影响：集中讨论NOTCH1、SF3B1和TP53
B-cell receptor pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma
B细胞受体信号通路抑制治疗慢性淋巴细胞白血病和淋巴浆细胞淋巴瘤
Diagnosis: When and how, FISH vs. IHC
诊断：何时诊断以及如何诊断：荧光原位杂交法（FISH）与免疫组织化学法（IHC）的比较研究
Impact of MYC on malignant behavior
MYC基因对恶性行为的影响
Double hit lymphomas: Current paradigms and novel treatment approaches
二次打击淋巴瘤：当前治疗模式及新型治疗方法
Optimal disease surveillance strategies in non-Hodgkin lymphoma
非霍奇金淋巴瘤的最佳疾病监测策略
Current survivorship recommendations for patients with Hodgkin lymphoma: Focus on late effects
当前针对霍奇金淋巴瘤患者生存情况的推荐意见：聚焦晚期症状
Caring for the long-term survivor after allogeneic stem cell transplantation
关注异基因造血干细胞移植后患者的长期生存
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
氟脱氧葡萄糖-正电子发射断层成像（FDG-PET）在早期霍奇金淋巴瘤疾病预后中的作用
The classical Hodgkin lymphoma tumor microenvironment: Macrophages and gene expression-based modeling
经典型霍奇金淋巴瘤微环境：基于巨噬细胞和基因表达建模
Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era
Brentuximab vedotin治疗复发性经典型霍奇金淋巴瘤
Indolent lymphoma: Follicular lymphoma and the microenvironment—insights from the microscope
惰性淋巴瘤: 从显微镜透视滤泡淋巴瘤和微环境
Indolent lymphoma: Follicular lymphoma and the microenvironment—insights from gene expression profiling
惰性淋巴瘤: 从基因表达透视滤泡性淋巴瘤和微环境
Therapeutic targeting of microenvironment in follicular lymphoma
针对滤泡性淋巴瘤微环境的靶向治疗
Screening for and management of hepatitis B reactivation in patients treated with anti-B-cell therapy
抗B细胞治疗后患者体内HBV病毒再活化的筛查和管理
Lymphoma and HIV infection: Five questions
淋巴瘤与HIV感染：五项问题
Hepatitis C virus-associated B-cell non-Hodgkin lymphoma
丙型肝炎病毒相关B细胞非霍奇金淋巴瘤
